Vaxart (VXRT) Return on Equity [ROE] (2011 - 2026)
Vaxart (VXRT) recorded Return on Equity [ROE] of 43.73% in Q2 2026, up 188.05 percentage points from -144.32% a year earlier and up 2.94 percentage points from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Vaxart reported Return on Equity [ROE] of 22.26%, up 136.96 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of +69.51 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -114.71% in FY2024 (-16.77 pp), -97.94% in FY2023 (-25.65 pp), -72.29% in FY2022 (-26.96 pp) and -45.33% in FY2021 (+1.93 pp).
- The Q2 2026 figure is the highest quarterly Return on Equity [ROE] in data going back to Q4 2011.
- On a year-over-year basis, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of +54.97 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 188.05 percentage points in Q2 2026, against a drop of 72.59 percentage points in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at 40.78% (Q1 2026), 28.51% (Q4 2025) and -170.05% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.97% |
| 10 | Vaxart | 106.67 Mn | 42.67 Mn | - | 43.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.73% |
| Mar 31, 2026 | 40.78% |
| Dec 31, 2025 | 28.51% |
| Sep 30, 2025 | -170.05% |
| Jun 30, 2025 | -144.32% |
| Mar 31, 2025 | -111.19% |
| Dec 31, 2024 | -105.13% |
| Sep 30, 2024 | -97.45% |
| Jun 30, 2024 | -111.50% |
| Mar 31, 2024 | -144.05% |
| Dec 31, 2023 | -127.53% |
| Sep 30, 2023 | -113.68% |
| Jun 30, 2023 | -115.45% |
| Mar 31, 2023 | -107.61% |
| Dec 31, 2022 | -92.53% |
| Sep 30, 2022 | -78.83% |
| Jun 30, 2022 | -60.03% |
| Mar 31, 2022 | -44.96% |
| Dec 31, 2021 | -35.91% |
| Sep 30, 2021 | -31.41% |
API Access
Vaxart Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();